2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Affiliations

• ¹ Department of Cardiology, Charite Universitätsmedizin Berlin, Berlin Institute of Health (BIH), German Center of Cardiovascular Research (DZHK), Hindenburgdamm 30, 12203 Berlin, Germany.
• ² National Institute for Health and Medical Research (INSERM), University of Pierre and Marie Curie, Pitié-Salpêtrière Hospital, Paris, France.
• ³ European Atherosclerosis Society, Gothenburg, Sweden.
• ⁴ Paris-Diderot-Sorbonne University and Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France.
• ⁵ Institute of Cardiovascular Research, Ninewells Hospital and Medical School, Dundee, UK.
• ⁶ Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, and Wallenberg Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.
• ⁷ Lipid Clinic, Point Medical, and Department of Cardiology, CHU Dijon-Bourgogne, Dijon, France.
• ⁸ Division of Cardiovascular Medicine, Division of Translational Research and Clinical Epidemiology, Wayne State University School of Medicine, Detroit, MI, USA.
• ⁹ Department of Internal Medicine III, Martin-Luther-University Halle/Wittenberg, University Hospital, Halle/Saale, Germany.
• ¹⁰ Trinity College, Dublin, Ireland.
• ¹¹ Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
• ¹² Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
• ¹³ University Heart Center, Department of Cardiology, University Hospital Zurich, and Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.
• ¹⁴ Heart Failure Unit, Cardiac Department, G Da Saliceto Hospital, Piacenza, Italy.
• ¹⁵ Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK.
• ¹⁶ Sahlgrenska University Hospital, Gothenburg, Sweden.
• ¹⁷ Department of Cardiology, Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland.
• ¹⁸ Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
• ¹⁹ Cardiology Department, CCUL, CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal.
• ²⁰ Department of Cardiology, Hacettepe University, Ankara, Turkey.
• ²¹ Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
• ²² Department of Pharmacological and Biomolecular Sciences, University of Milan and Multimedica IRCSS Milano, Italy.